P rospective studies in Europe and the United
States have shown that serum total cholesterol concentration is positively associated with the subsequent risk of coronary heart disease,1-3 whereas high-density lipoprotein cholesterol (HDL-C) concentration is inversely associated with the risk.4-'0 Three prospective studies in Japan have shown a direct association between serum total cholesterol and coronary heart disease incidence in Japan.11-13 A study of Chinese workers also showed a direct association between serum total cholesterol and mortality from coronary heart disease.14 Other small prospective studies of rural Japanese have failed to show an association between serum total cholesterol and coronary heart disease. 15 The small number of publications on blood lipids and coronary heart disease associations in Japan and other Asian countries is in part due to the low incidence and mortality of coronary heart disease14"16-'8 and low population level of serum total cholesterol. '14"1518 The contribution of HDL-C to coronary heart disease when total cholesterol is low, as in Japan and China, is uncertain because no prospective study in these countries has been reported. Studies in Western countries have not provided sufficient data on the relation between HDL-C and coronary heart disease at a low total cholesterol level, for example, <5.2 mmol/L (200 mg/ dL), because the prevalence of such low cholesterol levels is relatively small.
To examine the association between HDL-C and incident coronary heart disease at low total cholesterol levels, an 8-year prospective study was conducted among 6408 middle-aged male workers in urban companies, in which approximately 80% of the subjects had total cholesterol concentrations <5.2 mmol/L. The relation between HDL-C and stroke was also examined.
Methods
The subjects were 6624 male workers of 13 industrial companies in Osaka, Japan, 40 to 59 years old, who participated in cardiovascular risk surveys between 1979 and 1986 and had no history of coronary heart disease or stroke. Of these 6624 men, 6408 (97%) who had HDL-C measured were included into the analysis. Eighteen subjects (0.3%) using drugs affecting lipid levels were included in the analysis because doing so had little impact on results. Intake of selected nutrients in this population was as follows: calories Baseline Examination
The baseline examination for a participant was defined as the first survey with an HDL-C measurement, with a single blood sample used to define lipid levels. A total of 4009 (63%) of the 6408 participants were fasting at least 8 hours.
Blood was obtained from an antecubital vein, and serum was separated. After precipitation by heparin-manganese, HDL For fasting participants (n=4009), low-density lipoprotein cholesterol (LDL-C) was calculated22 as the total cholesterol value minus the HDL-C value minus the value (triglyceride/5).
First-and fifth-phase blood pressures were measured one or two times by trained observers using a standard mercury sphygmomanometer with the patient in the sitting position after at least a 5-minute rest. The first reading of blood pressures was used for the analysis. Body mass index was computed as weight (kilograms) divided by squared height (meters squared). Daily smoking habit and weekly alcohol intake were obtained by well-trained nurse interviewers.
Ascertainment of Incident Cardiovascular Disease and Death
Subjects with HDL-C measured were followed up to determine coronary heart disease and stroke end points through 1991. Follow-up was terminated at noncardiovascular death (n=73) or retirement (leaving the company) (n=1371). The age distribution at retirement for the 1371 men who left the company was 40 to 44 years, 4%; 45 to 49 years, 7%; 50 to 54 years, 13%; 55 to 59 years, 46%; 60 to 64 years, 29%; and 65 to 69 years, 1%.
Men who retired and those who did not had no consistent differences in age-specific mean values of HDL-C and other risk characteristics (Table 1 ). The age-adjusted mean value of HDL-C for men aged 40 to 59 years was similar between the two groups, whereas the mean value of serum total cholesterol and usual alcohol intake was slightly lower in men who retired than in men who did not.
Cardiovascular disease end points were ascertained via four sources: death certificates, absenteeism reports due to sickness, insurance claims to companies, and annual risk factor surveys. To validate the diagnosis, all living patients were visited or invited to risk factor surveys; study physicians obtained medical history, a standard ECG for coronary heart disease patients, and a neurological examination for stroke patients. For deaths, histories were obtained from the patient's family and/or colleagues who observed the incident. For both fatal and nonfatal cases, medical records at company clinics and/or local hospitals also were reviewed.
The criteria for coronary heart disease were modified from those of a World Health Organization Expert Committee. 23 Painless types of coronary heart disease were not investigated because of difficulty with ascertainment. "Definite" myocardial infarction was indicated by typical chest pain (lasting for 30 minutes or longer) with the appearance of abnormal and persistent Q or QS waves or changes in cardiac enzyme activity or both. "Suspect" myocardial infarction was indicated by typical chest pain without positive ECG and enzyme activity findings. Angina pectoris was defined as repeated episodes of chest pain during effort, especially when walking, usually disappearing rapidly after the cessation of effort or on use of sublingual nitroglycerin. Definite or suspect myocardial infarction and angina pectoris were combined and presented as coronary heart disease. The criteria24 for stroke and type of stroke were modified criteria of Millikan,2' which we described in detail elsewhere. 18 
Statistical Analysis
Mean values of baseline characteristics were compared between men who developed coronary heart disease, definite myocardial infarction, or stroke and men who remained free of cardiovascular disease using the t test or ANCOVA. The incidence rates per 1000 person-years for coronary heart disease and for stroke were calculated by quartiles of serum total cholesterol and HDL-C. The incidence rates were adjusted by the direct method of standardization to the age distribution of the total 6408 subjects analyzed.
Proportional hazards regression models26 were used to examine the relations of these serum lipids with the incidence 14 angina pectoris) and 33 of stroke (7 cerebral hemorrhage, 20 cerebral infarction, and 6 other types of stroke). Among the fasting participants (n=4009), there were 35 cases of coronary heart disease and 24 cases of stroke. Table 2 shows mean values of risk characteristics at baseline for coronary heart disease and stroke cases and for those who remained free of cardiovascular disease.
Compared with men free of cardiovascular disease, those with incident coronary heart disease had a significantly lower mean value of HDL-C and higher mean values of serum total cholesterol, systolic and diastolic blood pressures, and body mass index. The number of cigarettes smoked per day was higher and mean alcohol intake was lower in men developing coronary heart disease than in those free of cardiovascular disease. Adjustment for age did not alter these findings.
Mean HDL-C levels also were compared between men with coronary heart disease and men free of cardiovascular disease after adjustment for age, total serum cholesterol, body mass index, cigarette smoking, and alcohol intake. Adjusted mean values of HDL-C were 1.28 mmol/L for coronary heart disease and 1.46 mmol/L for men free of cardiovascular disease (difference, P=.0002). Among Table 3 provides the number of cases, age-adjusted incidence rates (per 1000 person-years), and multivariate-adjusted relative risks of coronary heart disease, definite myocardial infarction, and stroke by quartiles of serum total cholesterol concentration. For both coronary heart disease and definite myocardial infarction, the age-adjusted incidence rate and the relative risk were lowest in the lowest cholesterol quartile (<4.50 mmol/L) and increased with higher serum total cholesterol quartiles. According to a proportional hazards regression model adjusting for age, HDL-C, systolic blood pressure, body mass index, number of cigarettes, and usual alcohol intake, this positive association was statistically significant for both coronary heart disease and definite myocardial infarction. Multivariateadjusted relative risk (95% confidence interval [CI]) in the highest cholesterol quartile compared with the lowest was 4.89 (1.84 to 12.9) for coronary heart disease and 5.14 (1.12 to 23.6) for definite myocardial infarction. Stated differently, a 0.026-mmol/L (1 mg/dL) greater serum total cholesterol concentration was associated with 1.9% greater absolute risk of both coronary heart disease and definite myocardial infarction. On the other hand, there was a U-shaped relation between serum total cholesterol and stroke incidence: The incidence rates and relative risks were higher in both the lowest and highest cholesterol quartiles than the middle quartiles. Table 4 shows the HDL-C data. For both coronary heart disease and definite myocardial infarction, the incidence rate was highest in the lowest HDL-C quartile (< 1.24 mmol/L) and decreased significantly with higher HDL-C quartiles. Multivariate-adjusted relative risk (95% CI) in the lowest quartile of HDL-C with the No association was evident between HDL-C and the incidence of stroke. In a subsample analysis using only fasting participants controlling for age, systolic blood pressure, body mass index, number of cigarettes, usual alcohol intake, and LDL-C, the regression coefficients (SE) for HDL-C in relation to coronary heart disease and definite myocardial infarction were -2.28 (0.77) (P=.003) and -2.39 (1.17) (P=.04), respectively. The results adjusted for LDL-C were similar to the nonadjusted data of the total sample.
The inverse association of HDL-C level with the incidence of coronary heart disease and definite myocardial infarction was apparent both among men with serum total cholesterol <5.69 mmol/L (mean total cholesterol, 4.76 mmol/L) and with serum total cholesterol level .5.69 mmol/L (mean total cholesterol, 6.26 mmol/L) ( Table 5 ). The inverse association was statistically significant and the magnitude of the association was similar in both the lower and higher total cholesterol subgroups. No interaction was found between HDL-C and total cholesterol in relation to the diseases according to the proportional hazards model (P=.88 for coronary heart disease and P=.98 for definite myocardial infarction).
In the subsample of fasting participants with control for LDL-C, the regression coefficient (SE) of HDL-C (mmol/L) for coronary heart disease was -2.89 (1.13) (P=.01) in men with serum total cholesterol <5.69 mmol/L and -2.23 (1.06) (P=.04) in those with serum total cholesterol >5.69 mmol/L. The respective regression coefficients (SE) of HDL-C for definite myocardial infarction were -2.86 (1.84) (P=.12) and -2.60 (1.55) (P=.09). The results adjusted for LDL-C were similar to the nonadjusted data of the total sample.
Discussion
The present study showed that serum HDL-C and total cholesterol were inversely and independently associated with the incidence of coronary heart disease in middle-aged Japanese men. These results are consistent with other epidemiological studies in the United States and European countries.2 8 Chen et al14 reported a positive relation between serum total cholesterol and mortality from coronary heart disease below the range of cholesterol values generally seen in Western populations. Our study confirms that serum total cholesterol concentration is positively associated with coronary heart disease incidence even at low cholesterol levels.
The uniqueness of this study is that the protective association of HDL-C with coronary heart disease was found in men whose level of serum total cholesterol is relatively low. persons at greater risk of coronary heart disease. However, the cost-benefit of such measurement to prevent coronary heart disease is, of course, not established.
There was no association evident between HDL-C and stroke. A prospective study29 of Japanese living in Hawaii reported an insignificant inverse association between HDL-C and stroke. Several clinical and pathological studies reported that HDL-C levels were lower in patients with cerebral infarction in cortical artery regions than in those with no stroke or cerebral infarction in penetrating artery regions.34-36 The present sample size, however, did not allow us to examine relations of HDL-C to subtype of cerebral infarction.
A drawback of this study is that we did not identify cardiovascular disease events after men left employment in the participating companies. However, there were no apparent differences in age-specific or ageadjusted mean values of baseline coronary risk factors, including HDL-C, between men who left employment and men who did not. Thus, the withdrawal of these men is unlikely to affect the results substantially.
Survey follow-up was terminated mostly between ages 55 and 64 years, meaning the results are generalizable primarily to "premature" coronary heart disease in urban Japanese men. As premature coronary heart disease has a large impact on years of productivity, the findings are important.
Conclusions
The present study indicated an independent inverse relation of HDL-C and total cholesterol with coronary heart disease in a population with low total serum cholesterol concentrations. Because cigarette smoking, body mass index, and physical activity were strongly correlated with HDL-C, as reported previously in our study37'38 and in other studies,4,6'03940 smoking cessation, weight control, and exercise probably would be helpful in the prevention of coronary heart disease in Japanese as well as US and European men.
